{"id":8142,"date":"2025-06-10T06:41:55","date_gmt":"2025-06-10T10:41:55","guid":{"rendered":"https:\/\/liamfoundation.com\/maladie-mitochondriale-troubles-genetiques-de-lenergie\/"},"modified":"2025-06-10T09:31:35","modified_gmt":"2025-06-10T13:31:35","slug":"maladie-mitochondriale-troubles-genetiques","status":"publish","type":"post","link":"https:\/\/liamfoundation.com\/fr\/maladie-mitochondriale-troubles-genetiques\/","title":{"rendered":"Maladie mitochondriale : Troubles g\u00e9n\u00e9tiques de l&#8217;\u00e9nergie"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-post\" data-elementor-id=\"8142\" class=\"elementor elementor-8142\" data-elementor-post-type=\"post\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-7b92e2cb elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"7b92e2cb\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-7bf14055\" data-id=\"7bf14055\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-inner-section elementor-element elementor-element-4769e5d elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"4769e5d\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-inner-column elementor-element elementor-element-65c4741\" data-id=\"65c4741\" data-element_type=\"column\" data-e-type=\"column\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-bd2d84d elementor-widget elementor-widget-text-editor\" data-id=\"bd2d84d\" data-element_type=\"widget\" data-e-type=\"widget\" data-settings=\"{&quot;_animation&quot;:&quot;none&quot;}\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>R\u00e9sum\u00e9 rapide : Ce qu&#8217;il faut retenir :<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-9b8ec51 elementor-widget elementor-widget-text-editor\" data-id=\"9b8ec51\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<ul><li><p><span style=\"color: #ffffff;\">Les <strong>maladies mitochondriales<\/strong> sont des <strong>troubles g\u00e9n\u00e9tiques<\/strong> qui <strong>alt\u00e8rent la capacit\u00e9 de l&#8217;organisme \u00e0 produire de l&#8217;\u00e9nergie cellulaire<\/strong>. Ils affectent principalement les organes \u00e0 forte consommation d&#8217;\u00e9nergie tels que le cerveau, les muscles et le c\u0153ur.<\/span><\/p><\/li><li data-start=\"406\" data-end=\"509\"><p data-start=\"408\" data-end=\"509\"><span style=\"color: #ffffff;\">Il existe plus de <strong>300 types connus<\/strong>, dont le <strong>syndrome de MELAS<\/strong>, le <strong>syndrome de MERRF<\/strong>, le <strong>syndrome de Leigh<\/strong> et le <strong>syndrome de LHON<\/strong>.<\/span><\/p><\/li><li data-start=\"510\" data-end=\"621\"><p data-start=\"512\" data-end=\"621\"><span style=\"color: #ffffff;\">Les mutations peuvent se produire dans l&#8217;<strong>ADN mitochondrial (ADNmt)<\/strong> ou dans l&#8217;<strong>ADN nucl\u00e9aire<\/strong>, avec diff\u00e9rents modes de transmission h\u00e9r\u00e9ditaire.<\/span><\/p><\/li><li data-start=\"622\" data-end=\"721\"><p data-start=\"624\" data-end=\"721\"><span style=\"color: #ffffff;\">Le <strong>diagnostic comprend<\/strong> des tests g\u00e9n\u00e9tiques, des analyses sanguines, des examens d&#8217;imagerie et parfois des biopsies musculaires.<\/span><\/p><\/li><li data-start=\"722\" data-end=\"853\"><p data-start=\"724\" data-end=\"853\"><span style=\"color: #ffffff;\">Il n&#8217;existe <strong>aucun rem\u00e8de connu<\/strong>, mais des <strong>traitements tels que la CoQ10<\/strong>, la <strong>L-carnitine<\/strong> et la <strong>kin\u00e9sith\u00e9rapie<\/strong> peuvent am\u00e9liorer la qualit\u00e9 de vie.<\/span><\/p><\/li><li data-start=\"854\" data-end=\"961\"><p data-start=\"856\" data-end=\"961\"><span style=\"color: #ffffff;\">La <strong>recherche progresse<\/strong>, avec des avanc\u00e9es prometteuses dans le <strong>domaine de la th\u00e9rapie g\u00e9nique<\/strong> et des<strong> antioxydants cibl\u00e9s<\/strong>.<\/span><\/p><\/li><\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<div class=\"elementor-element elementor-element-7a211e3a elementor-widget elementor-widget-text-editor\" data-id=\"7a211e3a\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>Vous vous sentez d\u00e9pass\u00e9 par les termes m\u00e9dicaux complexes et les informations peu claires sur les maladies mitochondriales ? Vous n&#8217;\u00eates pas seul. Ce guide explique les aspects scientifiques des troubles mitochondriaux, des mutations de l&#8217;ADN aux probl\u00e8mes de production d&#8217;\u00e9nergie, de mani\u00e8re claire et concr\u00e8te pour les familles et les patients. D\u00e9couvrez comment la recherche de pointe et les strat\u00e9gies centr\u00e9es sur le patient permettent de mieux comprendre et prendre en charge cette maladie complexe.<\/p><h2><strong>Table des mati\u00e8res<\/strong><\/h2><ol><li><a href=\"#understanding-mitochondrial-disease\">Understanding Mitochondrial Disease: Basics and Definitions<\/a><\/li><li><a href=\"#genetic-origins\">Genetic Origins and Inheritance Patterns<\/a><\/li><li><a href=\"#types-and-symptoms\">Types of Mitochondrial Disease and Their Symptoms<\/a><\/li><li><a href=\"#diagnosis-and-management\">Diagnosis, Treatment and Disease Management<\/a><\/li><\/ol><h2 id=\"understanding-mitochondrial-disease\">Comprendre les maladies mitochondriales : notions fondamentales et d\u00e9finitions<\/h2><h3>Que sont les mitochondries et quelle est leur fonction ?<\/h3><p>Les mitochondries sont de minuscules organites cellulaires responsables de la production d&#8217;\u00e9nergie. Elles <strong>transforment les nutriments en ad\u00e9nosine triphosphate (ATP)<\/strong>, la source d&#8217;\u00e9nergie de l&#8217;organisme. Ce processus, appel\u00e9 phosphorylation oxydative, alimente des fonctions importantes telles que les contractions musculaires et la transmission nerveuse. Le bon fonctionnement des mitochondries est essentiel pour les tissus \u00e0 forte consommation d&#8217;\u00e9nergie comme le cerveau et le c\u0153ur. <a href=\"https:\/\/liamfoundation.com\/\">The Liam Foundation<\/a> souligne leur r\u00f4le dans la sant\u00e9 cellulaire.<\/p><p>Les mitochondries g\u00e9n\u00e8rent 90 % de l&#8217;\u00e9nergie cellulaire gr\u00e2ce \u00e0 un processus complexe impliquant la cha\u00eene de transport des \u00e9lectrons et la synth\u00e8se d&#8217;ATP. Elles d\u00e9pendent \u00e0 la fois de l&#8217;ADN mitochondrial (ADNmt) et de l&#8217;ADN nucl\u00e9aire pour fonctionner correctement. Les <strong>mutations perturbent la production d&#8217;\u00e9nergie<\/strong>, ce qui a des r\u00e9percussions sur des organes tels que les muscles, le cerveau et le foie. Cette perturbation est \u00e0 l&#8217;origine des maladies mitochondriales, qui touchent en premier lieu les tissus d\u00e9pendants de l&#8217;\u00e9nergie. Les mitochondries r\u00e9gulent \u00e9galement l&#8217;apoptose et l&#8217;\u00e9quilibre calcique, ce qui souligne leur importance cellulaire plus large.<\/p><h3>D\u00e9finition des maladies et troubles mitochondriaux<\/h3><p>Les maladies mitochondriales englobent les troubles g\u00e9n\u00e9tiques caus\u00e9s par des mutations de l&#8217;ADN mitochondrial ou de l&#8217;ADN nucl\u00e9aire. <strong>Ces anomalies alt\u00e8rent la production d&#8217;\u00e9nergie, entra\u00eenant un dysfonctionnement cellulaire.<\/strong> Il en existe plus de 300 formes, qui touchent 1 naissance sur 4 000. Les sympt\u00f4mes varient en fonction des tissus (muscles, cerveau, c\u0153ur, etc.) qui souffrent d&#8217;un d\u00e9ficit \u00e9nerg\u00e9tique. Les tests g\u00e9n\u00e9tiques permettent d&#8217;identifier les mutations sp\u00e9cifiques \u00e0 l&#8217;origine de ces troubles.<\/p><table><thead><tr><th>Category<\/th><th>Primary Mitochondrial Disorders<\/th><th>Secondary Mitochondrial Dysfunction<\/th><\/tr><\/thead><tbody><tr><td>Origin<\/td><td>Genetic mutations (mtDNA or nuclear DNA)<\/td><td>Environmental factors, toxins, or secondary conditions<\/td><\/tr><tr><td>Energy Production<\/td><td>Direct impairment of ATP synthesis<\/td><td>Indirect effects on mitochondrial function<\/td><\/tr><tr><td>Examples<\/td><td>MELAS, MERRF, Leigh syndrome<\/td><td>Drug-induced (e.g., HIV treatments), aging-related decline<\/td><\/tr><\/tbody><\/table><p>Le dysfonctionnement mitochondrial affecte plus gravement les organes gourmands en \u00e9nergie tels que le cerveau, les muscles et le c\u0153ur. Cela explique des sympt\u00f4mes tels que la faiblesse musculaire, les troubles neurologiques et les complications cardiaques. La variabilit\u00e9 dans la pr\u00e9sentation des sympt\u00f4mes refl\u00e8te les diff\u00e9rences dans les types de mutations et l&#8217;implication des tissus. Comme indiqu\u00e9 dans <a href=\"https:\/\/www.nature.com\/articles\/nrendo.2016.151\" target=\"_blank\" rel=\"noopener\">Nature Reviews Endocrinology<\/a>, Les manifestations cliniques d\u00e9pendent de la <strong>d\u00e9faillance des syst\u00e8mes mitochondriaux<\/strong> et de la gravit\u00e9 des d\u00e9ficits \u00e9nerg\u00e9tiques.<\/p><h2 id=\"genetic-origins\">Genetic Origins and Inheritance Patterns<\/h2><p>Mitochondrial disease arises from mutations in mitochondrial DNA (mtDNA) or nuclear DNA. mtDNA mutations, inherited maternally, affect mitochondrial function directly. Nuclear DNA mutations involve genes like POLG and TPRMB, which regulate mitochondrial processes. These defects <strong>disrupt energy production<\/strong>, causing diverse symptoms. <a href=\"https:\/\/liamfoundation.com\/\">The Liam Foundation<\/a> explains how genetic factors shape disease presentation.<\/p><ul><li><strong>Mutations in mtDNA<\/strong> cause mitochondrial disease<\/li><li><strong>mtDNA deletions<\/strong> disrupt mitochondrial energy production<\/li><li><strong>mtDNA depletion syndromes<\/strong> caused by nuclear gene mutations (TK2, POLG, DGUOK, SUCLA2) reduce mitochondrial DNA levels<\/li><li><strong>impair mitochondrial replication and repair<\/strong><\/li><\/ul><p>mtDNA is passed exclusively from mothers, explaining maternal inheritance patterns. Nuclear DNA mutations follow autosomal dominant or recessive patterns. For example, MELAS syndrome follows maternal inheritance, while POLG-related disorders follow autosomal patterns. These variations impact family planning, as risks differ between mutation types. Ontario data shows 1 in 3,989 people hospitalized with mitochondrial disease between 1988\u20132019, highlighting <strong>genetic transmission&#8217;s role<\/strong> in prevalence.<\/p><p>Spontaneous mutations account for cases without family history. These de novo changes occur during early development or gamete formation. Global estimates suggest 1 in 4,000 births involve mitochondrial disorders. While most follow inheritance patterns, <strong>new mutations contribute to disease emergence<\/strong>, explaining why some patients lack familial connections to mitochondrial disease.<\/p><h2 id=\"types-and-symptoms\">Types of Mitochondrial Disease and Their Symptoms<\/h2><h3>Common Mitochondrial Disease Syndromes<\/h3><p>Mitochondrial disease includes syndromes like MELAS and MERRF, caused by <strong>genetic mutations affecting energy production<\/strong>. These disorders impact high-energy tissues such as the brain and muscles. Symptoms vary widely, from neurological issues to muscle weakness. Over 300 forms exist, with MELAS and MERRF being among the most studied. Early diagnosis helps tailor care for better outcomes.<\/p><h3>Detailed Description of MELAS Syndrome<\/h3><p>MELAS involves stroke-like episodes, lactic acidosis, and muscle weakness. It\u2019s linked to mtDNA mutations, notably m.3243A&gt;G in MT-TL1. <strong>Patients often experience seizures and migraines<\/strong>. Lactic acid buildup causes metabolic stress. Brain imaging shows lesions outside typical stroke regions. Symptoms emerge in childhood, progressing unpredictably. Genetic testing confirms diagnosis. Treatments focus on symptom management and metabolic support, though no cure exists.<\/p><h3>Explanation of MERRF Syndrome<\/h3><p>MERRF features myoclonus epilepsy and ragged red fibers in muscle biopsies. Caused by MTTK mutations (A8344G in 80% of cases), it disrupts mitochondrial protein synthesis. Patients may develop ataxia and hearing loss. Onset typically occurs in childhood or adolescence. The condition\u2019s hallmark is <strong>clusters of abnormal mitochondria<\/strong> in muscle cells, visible under specialized staining.<\/p><h3>Less Common Mitochondrial Disorders<\/h3><p>Leigh syndrome affects infants with neurological decline and respiratory issues. NARP (neuropathy, ataxia, retinitis pigmentosa) stems from MT-ATP6 mutations, causing vision loss and coordination problems. These rarer forms highlight <strong>mitochondrial DNA\u2019s role<\/strong> in diverse organ systems. Their clinical diversity complicates diagnosis but underscores the need for comprehensive genetic analysis.<\/p><h3>Detailed Description of Leber\u2019s Hereditary Optic Neuropathy and NARP<\/h3><p>Leber\u2019s hereditary optic neuropathy (LHON) causes sudden vision loss due to mtDNA mutations (MT-ND1, MT-ND4, MT-ND6). NARP involves retinal degeneration, peripheral neuropathy, and ataxia from MT-ATP6 variants. <strong>Both disorders demonstrate tissue-specific mitochondrial dysfunction.<\/strong> LHON primarily affects young adults, while NARP presents with progressive neurological decline. Early genetic testing is crucial for management.<\/p><h3>Explanation of Kearns-Sayre Syndrome and DNA Depletion Syndromes<\/h3><p>Kearns-Sayre syndrome features progressive external ophthalmoplegia, retinal degeneration, and heart block. It\u2019s tied to mtDNA deletions, often sporadic. Mitochondrial DNA depletion syndromes (MTDPS) <strong>result from nuclear gene mutations<\/strong> (TK2, POLG), reducing mtDNA levels. These syndromes cause severe myopathy or liver failure. Their autosomal recessive inheritance means both parents carry the mutation.<\/p><h3>Symptoms Across Body Systems<\/h3><div style=\"overflow: auto; max-width: 100%;\"><table><caption>Organ-Specific Symptoms of Mitochondrial Disease<\/caption><thead><tr><th>Organ\/System<\/th><th>Common Symptoms<\/th><th>Additional Notes<\/th><\/tr><\/thead><tbody><tr><td>Heart<\/td><td>Cardiomyopathy, arrhythmias<\/td><td>Requires regular cardiac monitoring; can lead to heart failure<\/td><\/tr><tr><td>Brain<\/td><td>Stroke-like episodes, seizures, developmental delays<\/td><td>Characteristic of MELAS; linked to brain lesions<\/td><\/tr><tr><td>Muscles<\/td><td>Weakness, fatigue, exercise intolerance<\/td><td>Reduced stamina and pain during activity<\/td><\/tr><tr><td>Eyes<\/td><td>Vision loss (LHON), ptosis, retinitis pigmentosa<\/td><td>LHON causes sudden vision loss; NARP includes retinal degeneration<\/td><\/tr><tr><td>Nervous System<\/td><td>Ataxia, neuropathy<\/td><td>Impacts coordination and nerve function<\/td><\/tr><tr><td>Digestive System<\/td><td>Motility issues (vomiting, diarrhea, constipation)<\/td><td>Swallowing or nutrient absorption challenges<\/td><\/tr><tr><td>Liver<\/td><td>Acute failure, elevated enzymes<\/td><td>Frequent in pediatric cases<\/td><\/tr><tr><td>Kidneys<\/td><td>Tubular dysfunction, electrolyte imbalances<\/td><td>Impairs waste filtration and fluid balance<\/td><\/tr><tr><td>Ears<\/td><td>Sensorineural hearing loss<\/td><td>Progressive loss from cochlear nerve damage<\/td><\/tr><tr><td>Pancreas<\/td><td>Diabetes mellitus<\/td><td>Beta-cell dysfunction<\/td><\/tr><\/tbody><\/table><\/div><h3>Symptom Variability and Progression<\/h3><p>Symptoms vary due to mutation type, tissue energy demands, and heteroplasmy levels. Some experience stable symptoms; others face progressive decline. Environmental factors and secondary conditions can trigger fluctuations. <strong>Energy deficits often worsen<\/strong> over time without intervention. Regular monitoring helps adapt care as disease evolves.<\/p><h3>Common Pathogenic Mechanisms<\/h3><p>Energy failure underlies all mitochondrial disorders, but high-energy tissues like the brain and muscles show earliest damage. mtDNA mutations accumulate in postmitotic cells, while nuclear DNA defects disrupt mitochondrial replication. This <strong>dual genetic origin explains diverse clinical presentations<\/strong>. Addressing energy deficits remains central to therapeutic strategies.<\/p><h2 id=\"diagnosis-and-management\">Diagnosis, Treatment and Disease Management<\/h2><h3>Diagnostic Approaches and Challenges<\/h3><p>Mitochondrial disease diagnosis involves clinical evaluation, family history analysis, and specialized testing. Doctors <strong>assess symptoms<\/strong> across organs like the brain, muscles, and heart. Bloodwork, genetic testing (mtDNA and nuclear DNA), and muscle biopsies help confirm diagnosis. Globally, 1 in 4,000 births is affected, with Ontario recording 3,069 hospitalizations between 1988\u20132019. Family history is important due to maternal or autosomal inheritance patterns. Genetic testing identifies mutations like POLG or MELAS, while imaging and biomarkers support clinical findings.<\/p><ul><li><strong>Blood and urine tests<\/strong> for lactic acidosis and metabolic markers<\/li><li><strong>Imaging (MRI, CT)<\/strong> for brain or organ involvement<\/li><li><strong>Muscle biopsy<\/strong> for ragged red fibers and enzyme activity<\/li><li><strong>Genetic testing<\/strong> (mtDNA sequencing, nuclear gene panels)<\/li><li><strong>Biomarkers<\/strong> like elevated CSF lactate and plasma pyruvate<\/li><\/ul><p>Genetic testing clarifies mitochondrial disease through mtDNA and nuclear DNA analysis. Whole-exome sequencing identifies <strong>pathogenic variants<\/strong> in genes like POLG. ClinGen\u2019s <a href=\"https:\/\/clinicalgenome.org\/affiliation\/40027\/\" target=\"_blank\" rel=\"noopener\">Mitochondrial Diseases Gene Curation Expert Panel<\/a> validates over 250 nuclear genes linked to mitochondrial disorders. Next-generation sequencing improves variant detection accuracy. Prenatal testing and carrier screening guide family planning. Emerging technologies like single-cell sequencing may refine diagnosis further, addressing current limitations in identifying low-level heteroplasmy.<\/p><h3>Treatment Options and Management Strategies<\/h3><p>Current mitochondrial disease management focuses on symptom relief and supportive care. <strong>No cure exists<\/strong>, so treatment personalizes to organ involvement. Supplements like CoQ10 and L-carnitine address energy production deficits. Dietary strategies (high-fat, low-carb) help some patients. Physical therapy maintains mobility, while medications target seizures or cardiac issues. Regular monitoring prevents complications. <a href=\"https:\/\/liamfoundation.com\/liam-foundation-empowering-families-coping-mitochondrial-disease\/\">Support programs<\/a> guide families through daily challenges.<\/p><p>Therapies include CoQ10 for mitochondrial dysfunction and antioxidant support. Creatine monohydrate improves energy storage in muscles. Carnitine aids fatty acid transport into mitochondria. Ketogenic or modified Atkin\u2019s diet benefits certain epilepsy-related syndromes. Avoid valproate due to liver toxicity risks. For MELAS, dichloroacetate may reduce lactic acidosis. Cardiac issues require pacemakers. Vision loss in LHON needs neuroprotective agents. <strong>Multidisciplinary care coordinates interventions<\/strong> across neurology, cardiology, and nutrition.<\/p><p>Patients benefit from controlled exercise programs to boost mitochondrial biogenesis. Low-intensity aerobic activity (e.g., walking) improves stamina without overexertion. Energy conservation techniques involve scheduling rest breaks and pacing activities. Environmental factors like extreme heat or cold worsen symptoms, so temperature regulation is important. Adaptive equipment (e.g., mobility aids) eases daily tasks. Sleep hygiene supports energy recovery. <strong>Work closely with specialists<\/strong> to balance activity and recovery.<\/p><h3>Emerging Treatments and Research Directions<\/h3><p>Research explores gene therapy for mtDNA mutations and nucleoside supplementation to stabilize mitochondrial DNA. EPI-743, a synthetic CoQ10 analog, shows promise in clinical trials. Antioxidants like idebenone improve vision in LHON. <a href=\"https:\/\/liamfoundation.com\/latest-news-blog\/\">Cutting-edge research<\/a> includes mitochondrial replacement therapy and small molecules targeting the electron transport chain. Stem cell approaches aim to repair defective mitochondria in affected tissues. These innovations may one day address root causes, but <strong>current focus remains on quality-of-life<\/strong> improvements through symptom management.<\/p><p>Mitochondrial disease stems from genetic mutations disrupting cellular energy, impacting vital organs like the brain and muscles. Early diagnosis through genetic testing and <strong>personalized management<\/strong>\u2014such as supplements or lifestyle adjustments\u2014can stabilize symptoms. As research advances, staying informed and proactive offers families hope for improved therapies and a future where mitochondrial dysfunction is met with clearer answers and stronger support.<\/p><h2>Questions &amp; Answer about Mitochondrial Disease<\/h2>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-31dea87 elementor-widget elementor-widget-accordion\" data-id=\"31dea87\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"accordion.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-accordion\">\n\t\t\t\t\t\t\t<div class=\"elementor-accordion-item\">\n\t\t\t\t\t<div id=\"elementor-tab-title-5221\" class=\"elementor-tab-title\" data-tab=\"1\" role=\"button\" aria-controls=\"elementor-tab-content-5221\" aria-expanded=\"false\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-accordion-icon elementor-accordion-icon-left\" aria-hidden=\"true\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-accordion-icon-closed\"><svg class=\"e-font-icon-svg e-fas-plus\" viewBox=\"0 0 448 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M416 208H272V64c0-17.67-14.33-32-32-32h-32c-17.67 0-32 14.33-32 32v144H32c-17.67 0-32 14.33-32 32v32c0 17.67 14.33 32 32 32h144v144c0 17.67 14.33 32 32 32h32c17.67 0 32-14.33 32-32V304h144c17.67 0 32-14.33 32-32v-32c0-17.67-14.33-32-32-32z\"><\/path><\/svg><\/span>\n\t\t\t\t\t\t\t\t<span class=\"elementor-accordion-icon-opened\"><svg class=\"e-font-icon-svg e-fas-minus\" viewBox=\"0 0 448 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M416 208H32c-17.67 0-32 14.33-32 32v32c0 17.67 14.33 32 32 32h384c17.67 0 32-14.33 32-32v-32c0-17.67-14.33-32-32-32z\"><\/path><\/svg><\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t<a class=\"elementor-accordion-title\" tabindex=\"0\">Can mitochondrial disease go away?<\/a>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t<div id=\"elementor-tab-content-5221\" class=\"elementor-tab-content elementor-clearfix\" data-tab=\"1\" role=\"region\" aria-labelledby=\"elementor-tab-title-5221\"><p>Unfortunately, <strong>mitochondrial disease is a chronic condition<\/strong>, and current research indicates that it cannot simply &#8220;go away&#8221; or enter remission. These diseases stem from <strong>genetic defects affecting the mitochondria<\/strong>, the energy powerhouses of our cells.<\/p><p>Since mitochondrial diseases are caused by <strong>underlying genetic issues<\/strong>, there is currently <strong>no known cure or possibility of spontaneous remission<\/strong>. The focus of treatment is on managing symptoms and providing supportive care to improve quality of life.<\/p><\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t<div class=\"elementor-accordion-item\">\n\t\t\t\t\t<div id=\"elementor-tab-title-5222\" class=\"elementor-tab-title\" data-tab=\"2\" role=\"button\" aria-controls=\"elementor-tab-content-5222\" aria-expanded=\"false\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-accordion-icon elementor-accordion-icon-left\" aria-hidden=\"true\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-accordion-icon-closed\"><svg class=\"e-font-icon-svg e-fas-plus\" viewBox=\"0 0 448 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M416 208H272V64c0-17.67-14.33-32-32-32h-32c-17.67 0-32 14.33-32 32v144H32c-17.67 0-32 14.33-32 32v32c0 17.67 14.33 32 32 32h144v144c0 17.67 14.33 32 32 32h32c17.67 0 32-14.33 32-32V304h144c17.67 0 32-14.33 32-32v-32c0-17.67-14.33-32-32-32z\"><\/path><\/svg><\/span>\n\t\t\t\t\t\t\t\t<span class=\"elementor-accordion-icon-opened\"><svg class=\"e-font-icon-svg e-fas-minus\" viewBox=\"0 0 448 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M416 208H32c-17.67 0-32 14.33-32 32v32c0 17.67 14.33 32 32 32h384c17.67 0 32-14.33 32-32v-32c0-17.67-14.33-32-32-32z\"><\/path><\/svg><\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t<a class=\"elementor-accordion-title\" tabindex=\"0\">What are mitochondria and what do they do?<\/a>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t<div id=\"elementor-tab-content-5222\" class=\"elementor-tab-content elementor-clearfix\" data-tab=\"2\" role=\"region\" aria-labelledby=\"elementor-tab-title-5222\"><p>Mitochondria are <strong>essential organelles within our cells responsible for energy production<\/strong>. They convert nutrients into <strong>ATP, the body&#8217;s primary energy source<\/strong>, through a process called oxidative phosphorylation, powering critical functions like muscle contractions and nerve signaling.<\/p><p>These tiny organelles <strong>generate 90% of cellular energy<\/strong>, relying on both mitochondrial DNA (mtDNA) and nuclear DNA to function correctly. When mutations occur, this <strong>energy production is disrupted<\/strong>, leading to mitochondrial diseases that can affect various organs and tissues.<\/p><\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t<div class=\"elementor-accordion-item\">\n\t\t\t\t\t<div id=\"elementor-tab-title-5223\" class=\"elementor-tab-title\" data-tab=\"3\" role=\"button\" aria-controls=\"elementor-tab-content-5223\" aria-expanded=\"false\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-accordion-icon elementor-accordion-icon-left\" aria-hidden=\"true\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-accordion-icon-closed\"><svg class=\"e-font-icon-svg e-fas-plus\" viewBox=\"0 0 448 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M416 208H272V64c0-17.67-14.33-32-32-32h-32c-17.67 0-32 14.33-32 32v144H32c-17.67 0-32 14.33-32 32v32c0 17.67 14.33 32 32 32h144v144c0 17.67 14.33 32 32 32h32c17.67 0 32-14.33 32-32V304h144c17.67 0 32-14.33 32-32v-32c0-17.67-14.33-32-32-32z\"><\/path><\/svg><\/span>\n\t\t\t\t\t\t\t\t<span class=\"elementor-accordion-icon-opened\"><svg class=\"e-font-icon-svg e-fas-minus\" viewBox=\"0 0 448 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M416 208H32c-17.67 0-32 14.33-32 32v32c0 17.67 14.33 32 32 32h384c17.67 0 32-14.33 32-32v-32c0-17.67-14.33-32-32-32z\"><\/path><\/svg><\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t<a class=\"elementor-accordion-title\" tabindex=\"0\">How do genetic mutations lead to mitochondrial disease?<\/a>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t<div id=\"elementor-tab-content-5223\" class=\"elementor-tab-content elementor-clearfix\" data-tab=\"3\" role=\"region\" aria-labelledby=\"elementor-tab-title-5223\"><p>Mitochondrial diseases are caused by <strong>mutations in either mitochondrial DNA (mtDNA) or nuclear DNA<\/strong>. These mutations directly affect the mitochondria&#8217;s ability to produce energy, leading to cellular dysfunction and a wide range of symptoms.<\/p><p>Mutations in mtDNA are <strong>inherited maternally<\/strong>, while nuclear DNA mutations can follow autosomal dominant or recessive patterns. These genetic defects <strong>disrupt energy production<\/strong>, causing diverse symptoms and impacting family planning decisions.<\/p><\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t<div class=\"elementor-accordion-item\">\n\t\t\t\t\t<div id=\"elementor-tab-title-5224\" class=\"elementor-tab-title\" data-tab=\"4\" role=\"button\" aria-controls=\"elementor-tab-content-5224\" aria-expanded=\"false\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-accordion-icon elementor-accordion-icon-left\" aria-hidden=\"true\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-accordion-icon-closed\"><svg class=\"e-font-icon-svg e-fas-plus\" viewBox=\"0 0 448 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M416 208H272V64c0-17.67-14.33-32-32-32h-32c-17.67 0-32 14.33-32 32v144H32c-17.67 0-32 14.33-32 32v32c0 17.67 14.33 32 32 32h144v144c0 17.67 14.33 32 32 32h32c17.67 0 32-14.33 32-32V304h144c17.67 0 32-14.33 32-32v-32c0-17.67-14.33-32-32-32z\"><\/path><\/svg><\/span>\n\t\t\t\t\t\t\t\t<span class=\"elementor-accordion-icon-opened\"><svg class=\"e-font-icon-svg e-fas-minus\" viewBox=\"0 0 448 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M416 208H32c-17.67 0-32 14.33-32 32v32c0 17.67 14.33 32 32 32h384c17.67 0 32-14.33 32-32v-32c0-17.67-14.33-32-32-32z\"><\/path><\/svg><\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t<a class=\"elementor-accordion-title\" tabindex=\"0\">What are some common types of mitochondrial disease?<\/a>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t<div id=\"elementor-tab-content-5224\" class=\"elementor-tab-content elementor-clearfix\" data-tab=\"4\" role=\"region\" aria-labelledby=\"elementor-tab-title-5224\"><p>Common mitochondrial syndromes include <strong>MELAS (Mitochondrial Encephalopathy, Lactic Acidosis, and Stroke-like episodes) and MERRF (Myoclonic Epilepsy with Ragged Red Fibers)<\/strong>. These conditions are caused by genetic mutations that impair energy production, affecting high-energy tissues like the brain and muscles.<\/p><p>Other, less common disorders include <strong>Leigh syndrome and NARP (Neuropathy, Ataxia, Retinitis Pigmentosa)<\/strong>. Each of these syndromes presents with a unique set of symptoms, highlighting the diverse ways in which mitochondrial dysfunction can manifest.<\/p><\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t<div class=\"elementor-accordion-item\">\n\t\t\t\t\t<div id=\"elementor-tab-title-5225\" class=\"elementor-tab-title\" data-tab=\"5\" role=\"button\" aria-controls=\"elementor-tab-content-5225\" aria-expanded=\"false\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-accordion-icon elementor-accordion-icon-left\" aria-hidden=\"true\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-accordion-icon-closed\"><svg class=\"e-font-icon-svg e-fas-plus\" viewBox=\"0 0 448 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M416 208H272V64c0-17.67-14.33-32-32-32h-32c-17.67 0-32 14.33-32 32v144H32c-17.67 0-32 14.33-32 32v32c0 17.67 14.33 32 32 32h144v144c0 17.67 14.33 32 32 32h32c17.67 0 32-14.33 32-32V304h144c17.67 0 32-14.33 32-32v-32c0-17.67-14.33-32-32-32z\"><\/path><\/svg><\/span>\n\t\t\t\t\t\t\t\t<span class=\"elementor-accordion-icon-opened\"><svg class=\"e-font-icon-svg e-fas-minus\" viewBox=\"0 0 448 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M416 208H32c-17.67 0-32 14.33-32 32v32c0 17.67 14.33 32 32 32h384c17.67 0 32-14.33 32-32v-32c0-17.67-14.33-32-32-32z\"><\/path><\/svg><\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t<a class=\"elementor-accordion-title\" tabindex=\"0\">How is mitochondrial disease diagnosed?<\/a>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t<div id=\"elementor-tab-content-5225\" class=\"elementor-tab-content elementor-clearfix\" data-tab=\"5\" role=\"region\" aria-labelledby=\"elementor-tab-title-5225\"><p>Diagnosing mitochondrial disease involves a comprehensive approach that includes <strong>clinical evaluation, family history analysis, and specialized testing<\/strong>. Doctors assess symptoms affecting various organs, such as the brain, muscles, and heart, to guide the diagnostic process.<\/p><p>Diagnostic tools include <strong>bloodwork, genetic testing (mtDNA and nuclear DNA), and muscle biopsies<\/strong>. Genetic testing can identify specific mutations, while imaging and biomarkers provide additional support for clinical findings.<\/p><\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t<div class=\"elementor-accordion-item\">\n\t\t\t\t\t<div id=\"elementor-tab-title-5226\" class=\"elementor-tab-title\" data-tab=\"6\" role=\"button\" aria-controls=\"elementor-tab-content-5226\" aria-expanded=\"false\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-accordion-icon elementor-accordion-icon-left\" aria-hidden=\"true\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"elementor-accordion-icon-closed\"><svg class=\"e-font-icon-svg e-fas-plus\" viewBox=\"0 0 448 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M416 208H272V64c0-17.67-14.33-32-32-32h-32c-17.67 0-32 14.33-32 32v144H32c-17.67 0-32 14.33-32 32v32c0 17.67 14.33 32 32 32h144v144c0 17.67 14.33 32 32 32h32c17.67 0 32-14.33 32-32V304h144c17.67 0 32-14.33 32-32v-32c0-17.67-14.33-32-32-32z\"><\/path><\/svg><\/span>\n\t\t\t\t\t\t\t\t<span class=\"elementor-accordion-icon-opened\"><svg class=\"e-font-icon-svg e-fas-minus\" viewBox=\"0 0 448 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M416 208H32c-17.67 0-32 14.33-32 32v32c0 17.67 14.33 32 32 32h384c17.67 0 32-14.33 32-32v-32c0-17.67-14.33-32-32-32z\"><\/path><\/svg><\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t<a class=\"elementor-accordion-title\" tabindex=\"0\">What treatments are available for mitochondrial disease?<\/a>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t<div id=\"elementor-tab-content-5226\" class=\"elementor-tab-content elementor-clearfix\" data-tab=\"6\" role=\"region\" aria-labelledby=\"elementor-tab-title-5226\"><p>Currently, there is <strong>no cure for mitochondrial disease<\/strong>, so management focuses on alleviating symptoms and providing supportive care. Treatment is personalized based on the specific organs affected and the individual&#8217;s needs.<\/p><p>Common therapies include <strong>supplements like CoQ10 and L-carnitine to address energy production deficits<\/strong>. Physical therapy helps maintain mobility, while medications can target specific symptoms like seizures or cardiac issues. Multidisciplinary care is essential to coordinate interventions across various specialties.<\/p><\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>R\u00e9sum\u00e9 rapide : Ce qu&#8217;il faut retenir : Les maladies mitochondriales sont des troubles g\u00e9n\u00e9tiques qui alt\u00e8rent la capacit\u00e9 de l&#8217;organisme \u00e0 produire de l&#8217;\u00e9nergie cellulaire. Ils affectent principalement les [&hellip;]<\/p>\n","protected":false},"author":37,"featured_media":8135,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[98],"tags":[],"class_list":["post-8142","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-leducation"],"_links":{"self":[{"href":"https:\/\/liamfoundation.com\/fr\/wp-json\/wp\/v2\/posts\/8142","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/liamfoundation.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/liamfoundation.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/liamfoundation.com\/fr\/wp-json\/wp\/v2\/users\/37"}],"replies":[{"embeddable":true,"href":"https:\/\/liamfoundation.com\/fr\/wp-json\/wp\/v2\/comments?post=8142"}],"version-history":[{"count":7,"href":"https:\/\/liamfoundation.com\/fr\/wp-json\/wp\/v2\/posts\/8142\/revisions"}],"predecessor-version":[{"id":8162,"href":"https:\/\/liamfoundation.com\/fr\/wp-json\/wp\/v2\/posts\/8142\/revisions\/8162"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/liamfoundation.com\/fr\/wp-json\/wp\/v2\/media\/8135"}],"wp:attachment":[{"href":"https:\/\/liamfoundation.com\/fr\/wp-json\/wp\/v2\/media?parent=8142"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/liamfoundation.com\/fr\/wp-json\/wp\/v2\/categories?post=8142"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/liamfoundation.com\/fr\/wp-json\/wp\/v2\/tags?post=8142"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}